Your Cells Have a Parking Brake. A New TEDx Talk Explains How Releasing It Could Slow Parkinson’s
BOSTON, Nov. 16, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
Your Cells Have a Parking Brake. A New TEDx Talk Explains How Releasing It Could Slow Parkinson’s
PR Newswire
BOSTON, Nov. 16, 2026
BOSTON, Nov. 16, 2026 /PRNewswire/ — Mitochondria are the power plants of the cell. When they wear out, a healthy cell clears them through a recycling process called mitophagy. In Parkinson’s disease, that cleanup stalls. Damaged mitochondria accumulate, and neurons pay the price.
In a TEDxBoston talk now online, Vincere Biosciences co-founder Andy Lee makes the case for USP30, a protein that holds back mitophagy. It acts as a parking brake on the cell’s recycling system. His team built small molecules to release it.
“Better is more important than longer,” Lee says in the talk. The goal is not simply more years, but years in which the brain’s cleanup system still works.
The target did not come from a hunch. Algorithms built on machine learning, graphs, and natural language processing read millions of papers no human could, ranked the targets, and classified the pathways. One answer kept rising to the top: USP30. It then took 723 iterations to build a potent, selective USP30 inhibitor. In aged mice, releasing that brake produced a sixfold increase in mitophagy in the brain cells most vulnerable in Parkinson’s.
The lead program is now in final preparation for first-in-human studies.
“For decades, futurists have imagined living long enough to live forever,” Lee says. “But I’ve always thought better is more important than longer.”
Watch the full 9-minute talk: https://youtu.be/qiVvIJTP6T8
Recorded live at TEDxBoston “Unlocking Longevity,” October 6, 2026, at WHOOP HQ in Boston, MA.
About Vincere Biosciences Inc.
Cambridge, MA-based Vincere Biosciences develops innovative, mechanism-driven therapeutics that target the intersection of aging and disease. Using proprietary computational tools and cutting-edge biology, Vincere is dedicated to discovering and developing small molecules that address the root causes of age-related conditions such as Parkinson’s and AKI, amongst others.
About NeuroInitiative
NeuroInitiative builds virtual-cell simulations to find cures for neurodegeneration. Its SEED platform models human disease in virtual cells to prioritize drug targets; its first prioritized target, USP30, became Vincere’s lead program.
Media Contact
Anahit Campbell, Strategic Initiatives Manager, Vincere Biosciences
Phone: 857-245-9492
Email: campbell@vincerebio.com
TEDxBoston is an independently organized TEDx event.
View original content:https://www.prnewswire.com/news-releases/your-cells-have-a-parking-brake-a-new-tedx-talk-explains-how-releasing-it-could-slow-parkinsons-302940832.html
SOURCE Vincere Biosciences



